morphictx.com was registered 8 years 5 months ago. It has a alexa rank of #2,901,571 in the world. It is a domain having .com extension. It is estimated worth of $ 480.00 and have a daily income of around $ 2.00. As no active threats were reported recently, morphictx.com is SAFE to browse.
Daily Unique Visitors: | 302 |
Daily Pageviews: | 604 |
Income Per Day: | $ 2.00 |
Estimated Worth: | $ 480.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | 11,600 |
Bing Indexed Pages: | Not Applicable |
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Very Poor |
WOT Privacy: | Very Poor |
WOT Child Safety: | Very Poor |
Alexa Rank: | 2,901,571 |
PageSpeed Score: | 87 ON 100 |
Domain Authority: | 49 ON 100 |
Bounce Rate: | Not Applicable |
Time On Site: | Not Applicable |
Total Traffic: | No Data |
Direct Traffic: | No Data |
Referral Traffic: | No Data |
Search Traffic: | No Data |
Social Traffic: | No Data |
Mail Traffic: | No Data |
Display Traffic: | No Data |
morphic announces corporate highlights and third quarter 2020 financial results
The Investor Relations website contains information about Morphic Therapeutic's business for stockholders, potential investors, and financial analysts.
For more information, visit www.morphictx.com. Cautionary Note Regarding Forward-Looking Statements. This press release contains “forward-looking” statements within the meaning...
Morphic Therapeutic | 2,529 followers on LinkedIn. Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases. Morphic Tx is joining a...
The Investor Relations website contains information about Morphic Therapeutic's business for stockholders, potential investors, and financial analysts.
Aug 25, 2020 · [email protected] 617.686.1718. Media Contact Tom Donovan, Ten Bridge Communications [email protected] 857.559.3397. Related Articles. More...
Nov 17, 2020 · WALTHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies...
Nov 17, 2020 · A live webcast of the company presentation will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be …
Members of the Morphic management team are scheduled to participate in a panel discussion at 8:45 a.m. ET on Wednesday, September 23, 2020, as well as present a …
The Investor Relations website contains information about Morphic Therapeutic's business for stockholders, potential investors, and financial analysts.
We would like to show you a description here but the site won’t allow us.
Sep 23, 2020 · [email protected] 617.686.1718. Media Contact Tom Donovan, Ten Bridge Communications [email protected] 857.559.3397. Related Articles. More...
Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on discoveries made in the lab of Scientific Founder Tim Springer,...
Company profile page for Morphic Therapeutic Inc including stock price, company news, press releases, executives, board members, and contact information
For more information, visit www.morphictx.com. Cautionary Note Regarding Forward-Looking Statements. This press release contains "forward-looking" statements within the meaning...
Oct 18, 2018 · [email protected] 781-996-0955 or Morphic Media Contact: Tom Donovan Ten Bridge Communications [email protected] 857-559-3397 << Back. The...
Nov 17, 2020 · A live webcast of the company presentation will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be...
WALTHAM, Mass., Nov. 17, 2020 -- Morphic Therapeutic , a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment of serious...
Morphic Therapeutic General Information Description. Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline...
WALTHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting...
H1 Headings: | 1 | H2 Headings: | Not Applicable |
H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 1 |
Google Adsense: | Not Applicable | Google Analytics: | UA-80278289-1 |
Domain Registrar: | GoDaddy.com, LLC |
---|---|
Registration Date: | 2016-06-15 8 years 5 months 2 days ago |
Last Modified: | 2016-06-15 8 years 5 months 2 days ago |
Host | IP Address | Country | |
---|---|---|---|
ns17.domaincontrol.com | 97.74.108.9 | United States | |
ns18.domaincontrol.com | 173.201.76.9 | United States |
Host | Type | TTL | Extra |
---|---|---|---|
morphictx.com | A | 1786 |
IP: 107.20.173.90 |
morphictx.com | NS | 3600 |
Target: ns17.domaincontrol.com |
morphictx.com | NS | 3600 |
Target: ns18.domaincontrol.com |
morphictx.com | SOA | 600 |
MNAME: ns17.domaincontrol.com RNAME: dns.jomax.net Serial: 2019062700 Refresh: 28800 Retry: 7200 Expire: 604800 |
morphictx.com | MX | 1800 |
Priority: 20 Target: us-smtp-inbound-2.mimecast.com |
morphictx.com | MX | 1800 |
Priority: 10 Target: us-smtp-inbound-1.mimecast.com |
morphictx.com | TXT | 1800 |
TXT: v=spf1 include:_netblocks.mimecast.com ~all |
morphictx.com | TXT | 1800 |
TXT: a:us-smtp-delivery-196.mimecast.com -all |
morphictx.com | TXT | 1800 |
TXT: 0ed1fe018ad0dc591fb25a486ea72281eec3b429 a4 |
morphictx.com | TXT | 1800 |
TXT: v=verifydomain MS=3765068 |
Fogyasztók.hu - fogyasztóvédelmi magazin